The SafeBoosC phase II randomised clinical trial: A treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants

  • Adelina Pellicer
  • , Gorm Greisen
  • , Manon Benders
  • , Olivier Claris
  • , Eugene Dempsey
  • , Monica Fumagalli
  • , Christian Gluud
  • , Cornelia Hagmann
  • , Lena Hellström-Westas
  • , Simon Hyttel-Sorensen
  • , Petra Lemmers
  • , Gunnar Naulaers
  • , Gerhard Pichler
  • , Claudia Roll
  • , Frank Van Bel
  • , Wim Van Oeveren
  • , Maria Skoog
  • , Martin Wolf
  • , Topun Austin

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The SafeBoosC phase II randomised clinical trial: A treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants'. Together they form a unique fingerprint.

Medicine and Dentistry